Organigram Holdings Inc. (NASDAQ:OGI) Q1 2023 Earnings Call Transcript

We’re very excited about the opportunity. But we’ve also know that we’ve come in with the kind of pricing that is the right price for that brand relative to the competitive set. So, I’m not sure I’ve given you a lot more clarity only to say that I wouldn’t say it’s a tweak, but it wasn’t a whole scale adjustment either.

Tamy Chen: Okay. Well, that’s still helpful incremental commentary on that. And last follow-up on this whole pricing discussion. This — you’re being a bit cautious in your guidance, which I understand with respect to your calling out the potential for continued price compression. I was wondering, are you able to — like do you have a sense in what — in your guidance or expectations, the sort of magnitude of price compression, your sort of expecting over fiscal ’23? And within that, I guess, higher level is — I think a couple of quarters ago, you had thought that maybe we were starting to see some stabilization in price, but it sounds like both from your comments today and your competitor that reported earlier that this price compression across the industry is still continuing.

Do you see, at some point, it will stabilize? Like how long do you think it might take to get there? Like what continues to drive this? When do you think we’ll be kind of out of this tunnel here?

Beena Goldenberg: Great. I’d love to know the edge to that. But let me perhaps address your question in this way. If you look at the overall supply of cannabis in the Canadian marketplace and you look at the size of the market and the demand, there is still a significant surplus of production coming out into the market. And while there is a lot of extra capacity with some of our competitors, they have extra flower, people will do what I might call silly things to get product out to try to generate some cash from that inventory. And so you’re right, a couple of quarters ago, I thought we had stabilized on flower. We were kind of had a few quarters of it that had stabilized. But we really see the — especially the large format flower prices are being compressed now.

And I think until the supply and demand gets aligned, this could always be a problem. There will always be somebody out there who might make a move that isn’t what I would say the best move for the overall industry, but might be the right thing for them. From our perspective, we did add capacity but we were adding capacity because our demand was greater than what we could supply. And so, we have confidence that we have customers for that extra power capacity. But we have some competitors who are producing a lot more flower than they have demand. And that’s what’s causing the volatility in pricing. Again, when will it stop when some of that capacity is taken out of the Canadian industry.

Operator: Our next question comes from the line of Ty Collin from Eight Capital. Your line is open.

Ty Collin: Thanks for taking my question and congrats on a great quarter here. I want to circle back to the balance sheet. Beena, could you talk about how you’re thinking about your cash position today? You’ve got $95 million on hand around $20 million of CapEx commitments remaining this year and you’re expecting to get to positive free cash flow by the end of the year. So that does leave quite a big cushion. Should we think of that as mostly dry powder for M&A? Or is there a chance you consider returning some of that to shareholders on cash flow and maybe pricing stabilize a little bit?